Concerns Rise Over Lung Cancer Screening Rates

Lung cancer detection and management are critical topics as experts highlight the importance of early screening and advancement in testing methods. Dr. Oleg Gligich emphasizes the role of circulating tumor DNA (ctDNA) testing for assessing treatment effectiveness and monitoring recurrence in lung cancer patients. In Montana, only 5% of high-risk individuals are being screened for lung cancer, which is significantly below the national average, prompting healthcare providers to launch initiatives aimed at improving early detection. Meanwhile, Susan Wojcicki, the late CEO of YouTube, called for increased research funding for lung cancer, particularly for non-smokers, as rates among never-smokers, especially women, are rising. The American Lung Association reports a 26% improvement in lung cancer survival rates over five years, but only 16% of eligible individuals are screened, highlighting a need for greater awareness and access to screenings. Despite the challenges, new screening technologies show promise in catching lung cancer at earlier stages, improving patient outcomes.